Treatment of Refractory Hematospermia With Finasteride: A Prospective Placebo-Controlled Study

    October 2023 in “ Bangladesh journal of urology ”
    Imtiaz Enayetullah, Md Asaduzzaman Rajib, Sharif Md Shahadat Ali Khan … Md Faisal Islam
    Studysummary This study in Bangladesh reports that 81% of patients with refractory idiopathic hematospermia showed remission after three months of finasteride treatment, significantly higher than the 27% remission rate in the placebo group, with results sustained for some time after stopping the medication.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on banglajol.info →
    Discuss this study in the Community →